TY - JOUR
T1 - Procedural success in transaxillary transcatheter aortic valve implantation according to type of transcatheter heart valve
T2 - results from the multicenter TAXI registry
AU - Schaefer, Andreas
AU - Bhadra, Oliver D.
AU - Conradi, Lenard
AU - Westermann, Dirk
AU - Kellner, Caroline
AU - De Backer, Ole
AU - Bajoras, Vilhelmas
AU - Sondergaard, Lars
AU - Qureshi, Waqas T.
AU - Kakouros, Nikolaos
AU - Aldrugh, Summer
AU - Amat-Santos, Ignacio
AU - Kaneko, Tsuyoshi
AU - Harloff, Morgan
AU - Teles, Rui
AU - Nolasco, Tiago
AU - Neves, Jose Pedro
AU - Abecasis, Miguel
AU - Werner, Nikos
AU - Lauterbach, Michael
AU - Sacha, Jerzy
AU - Krawczyk, Krzysztof
AU - Trani, Carlo
AU - Romagnoli, Enrico
AU - Mangieri, Antonio
AU - Condello, Francesco
AU - Regueiro, Ander
AU - Brugaletta, Salvatore
AU - Biancari, Fausto
AU - Niemelä, Matti
AU - Giannini, Francesco
AU - Toselli, Marco
AU - Ruggiero, Rossella
AU - Buono, Andrea
AU - Maffeo, Diego
AU - Bruno, Francesco
AU - Conrotto, Federico
AU - D’Ascenzo, Fabrizio
AU - Savontaus, Mikko
AU - Pykäri, Jouni
AU - Ielasi, Alfonso
AU - Tespili, Maurizio
AU - Cimmino, Michele
AU - Albanese, Michele
AU - Biondi-Zoccai, Giuseppe
AU - Corcione, Nicola
AU - Morello, Alberto
AU - Giordano, Arturo
N1 - Publisher Copyright:
© 2023, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.
PY - 2024
Y1 - 2024
N2 - Background: Transaxillary (TAx) transcatheter aortic valve implantation (TAVI) is a preferred alternative access in patients ineligible for transfemoral TAVI. Aims: This study used the Trans-AXillary Intervention (TAXI) registry to compare procedural success according to different types of transcatheter heart valves (THV). Methods: For the TAXI registry anonymized data of patients treated with TAx-TAVI were collected from 18 centers. Acute procedural, early and 1-month clinical outcomes were adjudicated in accordance with standardized VARC-3 definitions. Results: From 432 patients, 368 patients (85.3%, SE group) received self-expanding (SE) THV and 64 patients (14.8%, BE group) received balloon-expandable (BE) THV. Imaging revealed lower axillary artery diameters in the SE group (max/min diameter in mm: 8.4/6.6 vs 9.4/6.8 mm; p < 0.001/p = 0.04) but a higher proportion of axillary tortuosity in BE group (62/368, 23.6% vs 26/64, 42.6%; p = 0.004) with steeper aorta-left ventricle (LV) inflow (55° vs 51°; p = 0.002) and left ventricular outflow tract (LVOT)-LV inflow angles (40.0° vs 24.5°; 0.002). TAx-TAVI was more often conducted by right sided axillary artery in the BE group (33/368, 9.0% vs 17/64, 26.6%; p < 0.001). Device success was higher in the SE group (317/368, 86.1% vs 44/64, 68.8%, p = 0.0015). In logistic regression analysis, BE THV were a risk factor for vascular complications and axillary stent implantation. Conclusions: Both, SE and BE THV can be safely used in TAx-TAVI. However, SE THV were more often used and were associated with a higher rate of device success. While SE THV were associated with lower rates of vascular complications, BE THV were more often used in cases with challenging anatomical circumstances.
AB - Background: Transaxillary (TAx) transcatheter aortic valve implantation (TAVI) is a preferred alternative access in patients ineligible for transfemoral TAVI. Aims: This study used the Trans-AXillary Intervention (TAXI) registry to compare procedural success according to different types of transcatheter heart valves (THV). Methods: For the TAXI registry anonymized data of patients treated with TAx-TAVI were collected from 18 centers. Acute procedural, early and 1-month clinical outcomes were adjudicated in accordance with standardized VARC-3 definitions. Results: From 432 patients, 368 patients (85.3%, SE group) received self-expanding (SE) THV and 64 patients (14.8%, BE group) received balloon-expandable (BE) THV. Imaging revealed lower axillary artery diameters in the SE group (max/min diameter in mm: 8.4/6.6 vs 9.4/6.8 mm; p < 0.001/p = 0.04) but a higher proportion of axillary tortuosity in BE group (62/368, 23.6% vs 26/64, 42.6%; p = 0.004) with steeper aorta-left ventricle (LV) inflow (55° vs 51°; p = 0.002) and left ventricular outflow tract (LVOT)-LV inflow angles (40.0° vs 24.5°; 0.002). TAx-TAVI was more often conducted by right sided axillary artery in the BE group (33/368, 9.0% vs 17/64, 26.6%; p < 0.001). Device success was higher in the SE group (317/368, 86.1% vs 44/64, 68.8%, p = 0.0015). In logistic regression analysis, BE THV were a risk factor for vascular complications and axillary stent implantation. Conclusions: Both, SE and BE THV can be safely used in TAx-TAVI. However, SE THV were more often used and were associated with a higher rate of device success. While SE THV were associated with lower rates of vascular complications, BE THV were more often used in cases with challenging anatomical circumstances.
KW - TAVI
KW - TAVR
KW - Transaxillary
KW - Transcatheter valve therapy
KW - Valve disease
U2 - 10.1007/s00392-023-02216-1
DO - 10.1007/s00392-023-02216-1
M3 - Journal article
C2 - 37138103
AN - SCOPUS:85158129537
VL - 113
SP - 48
EP - 57
JO - Clinical Research in Cardiology
JF - Clinical Research in Cardiology
SN - 1861-0684
ER -